FDA approves Alzheimer's drug lecanemab from Eisai, Biogen

Federal drug regulators on Friday approved lecanemab, sold under the brand name Leqembi, an Alzheimer’s drug that appears to slow the disease.

Related Keywords

Chicago ,Illinois ,United States ,Toronto ,Ontario ,Canada ,Americans ,Ivan Cheung ,Marwan Sabbagh ,Marrwan Sabbagh ,Sharon Cohen ,Christopher Van Dyck ,Ken Alltucker ,Centers For Medicare ,Toronto Memory Program ,Barrow Neurological Institute ,Drug Administration ,Alzheimer Association ,Medicaid Services ,Northwestern University Feinberg School Of Medicine ,New England Journal ,Northwestern University Feinberg School ,Will Medicare ,